A decade of liver transplantation at Mayo Clinic in Florida

We have utilized deceased donor livers to maintain low mortality on the wait list, to provide a significantly high transplant rate, and to achieve excellent graft and patient outcomes at 3 months, one year, and 3 years, surpassing the national and expected averages. We have also shown that reLT remains a durable option for patients with recurrent disease including recurrent HCV, that DCD livers continue to be a viable source of donor grafts, and that LT in patients with high BMI produces acceptable outcomes.